KK2223 / Kyowa Kirin - LARVOL DELTA

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma (clinicaltrials.gov) - P1 | N=72 | Recruiting | Sponsor: Kyowa Kirin, Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Cutaneous T-cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Peripheral T-cell Lymphoma • T Cell Non-Hodgkin Lymphoma

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma (clinicaltrials.gov) - P1 | N=72 | Not yet recruiting | Sponsor: Kyowa Kirin, Inc. | N=34 ➔ 72

Enrollment change • First-in-human • Trial initiation date • Cutaneous T-cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Peripheral T-cell Lymphoma • Sezary Syndrome • T Cell Non-Hodgkin Lymphoma • ALK • TNFRSF8

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma (clinicaltrials.gov) - P1 | N=34 | Not yet recruiting | Sponsor: Kyowa Kirin, Inc. | N=17 ➔ 34

Enrollment change • First-in-human • Cutaneous T-cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Peripheral T-cell Lymphoma • Sezary Syndrome • T Cell Non-Hodgkin Lymphoma • ALK • TNFRSF8

2223-001: A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma (clinicaltrialsregister.eu) - P1 | N=17 | Not yet recruiting | Sponsor: Kyowa Kirin Inc.

First-in-human • New P1 trial • Cutaneous T-cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Peripheral T-cell Lymphoma • T Cell Non-Hodgkin Lymphoma

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma (clinicaltrials.gov) - P1 | N=72 | Not yet recruiting | Sponsor: Kyowa Kirin, Inc.

First-in-human • New P1 trial • Cutaneous T-cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Peripheral T-cell Lymphoma • T Cell Non-Hodgkin Lymphoma